Your Federal Congressional Representatives are now back in their home districts

The House of representatives control the purse strings of the entire Federal Budget… they could reduce or defund the DEA… they are back in their home districts.. they are meeting with their constituents .. you will never have a better opportunity to get your message across..  Contact their local district office and see when you can have a person meeting with them.. or they are having a town forum. They will never know or understand your concerns or issues.. unless you make sure that they hear directly from you !

Members of the U.S. House of Representatives wrapped up votes Wednesday evening ahead of the August recess. Most members left town later that night or on Thursday. We caught up with a couple of congressmen before they hit the road.Ohio Republican Rep. Jim Renacci pointed out that while there is more work to be done when the House comes back, he likes being able to talk with his constituents.

“It gives us a little break in the legislative period, but at the same time, gives us an opportunity to really understand what’s going on back home,” Renacci told us.

Like many members of Congress, Florida Democratic Rep. Ted Deutch is looking forward to holding a series of town hall meetings on the issues important to his constituents.

“I hope that people will come out and will participate and will share their views with me,” Deutch said. “That’s what I respond to. That’s the most important part of my job.”

Some of the major issues lawmakers will have to act on after the August recess include the Iran nuclear deal, a longer-term Highway Trust Fund bill, and the debt ceiling.

The U.S. Senate will adjourn for its August recess next week.

At CVS Health where “health is everything “

1-IMG_1884To the best of my knowledge, HOSPICE pts are exempt from any DEA oversight on controlled meds..  This was sent to CVS’ Face Book page.. A few prescribers have been successfully sued for failing to treat pain in end of life cancer pts.. they were not charged with malpractice but .. irresponsible professional negligence.  Is this just a lack of empathy or sympathy or another example of a healthcare DENIER…

No “DEATH PANELS” – YET -.. just more denial of medication coverage (Updated)

CVS strips Viagra, other top drugs, from insurance coverage

http://www.stltoday.com/business/local/cvs-strips-viagra-other-top-drugs-from-insurance-coverage/article_d7a69636-09e1-5ba0-a6ac-cd2e541d573c.html

There are three major PBM’s that control the majority of the market CVS Health, Express Scripts, United Health… just watch .. before the end of the year.. the other two will do same/similar deletion of meds covered… but.. there is NO COLLUSION going on.

Here is the full list of drugs dropped by CVS, according to CNN:

  • Abilify (antipsychotic)
  • Amitiza (irritable bowel disease)
  • Avonex (multiple sclerosis)
  • Bydureon (diabetes)
  • Carac (dermatology)
  • Cardizem (high blood pressure)
  • Clobetasol spray (dermatology)
  • Clobex spray (dermatology)
  • Cymbalta (depression)
  • Diovan (high blood pressure)
  • Exforge, including Exforge HCT (high blood pressure)
  • Extavia (multiple sclerosis)
  • Fluorouracil cream 0.5% (dermatology)
  • Fortesta (testosterone replacement)
  • Fosrenol (kidney disease)
  • Incruse Ellipta (Chronic obstructive pulmonary disease)
  • Intuniv (ADHD)
  • Invokameet (diabetes)
  • Invokana (diabetes)
  • Matzim LA (high blood pressure)
  • Monovisc (monovisc)
  • Noritate (dermatology)
  • Plegridy (multiple sclerosis)
  • Qsymia (anti-obesity)
  • Relistor (gastrointestinal)
  • Valcyte (anti-infective)
  • Viagra (erectile dysfunction)
  • Zubsolv (opioid dependence)

CVS Health Corp., which operates the nation’s second-biggest pharmacy benefit manager, said that next year it will exclude an additional 31 prescription medicines from insurance coverage, including Viagra and widely used treatments for diabetes and multiple sclerosis.

The 2016 excluded drugs, disclosed on Wednesday, also include Vivus Inc.’s weight loss treatment Qsymia, which last week was excluded from the 2016 formulary of CVS rival Express Scripts Holding Co. Vivus officials could not immediately be reached for comment.

Pharmacy benefit managers, or PBMs, which administer drug benefits for employers and health plans and also run large mail-order pharmacies, have been challenging the rising cost of new medications. When drugs are knocked off their formularies, patients may have to pay full price for them. PBMs often keep or dump a product depending on whether they can obtain favorable pricing.

 

Viagra, the world’s first approved pill for erectile dysfunction, has annual sales of $1.8 billion, including $1.3 billion in the United States. Cheaper generic versions are expected to be launched by December 2017.

“Pfizer is committed to ensuring patient access to our medicines,” the drugmaker said in an emailed statement.

The CVS formulary, however, does include Eli Lilly and Co.’s rival Cialis anti-impotence treatment.

Next year’s formulary will also exclude two interferon-based multiple sclerosis treatments from Biogen, big-selling Avonex and its new longer-acting Plegridy. Avonex, Biogen’s second-biggest product, has annual sales of almost $2.5 billion.

“Avonex and Plegridy have broad insurance coverage,” Biogen said in an emailed statement. “We are confident that patients will continue to have access to our medicines.”

Johnson & Johnson’s two-year-old diabetes treatment, Invokana, and a related combination treatment called Invokamet, will also be stripped from CVS coverage. Combined sales of the medicines have been growing by leaps and bounds, reaching $318 million in the second quarter. J&J did not have an immediate comment.

Another diabetes drug to be excluded from the CVS formulary is Bydureon, a once-weekly treatment from AstraZeneca Plc. CVS will favor instead similar treatments from Lilly and Novo Nordisk.

“Bydureon continues to have excellent access across commercial and non-commercial plans, including (Medicare) Part D,” AstraZeneca said.

Express Scripts, the nation’s biggest PBM, last week said it would boot about 20 additional medicines from its formulary in 2016.

Express Scripts said it can negotiate lower drug prices through its ability to exclude drugs from its coverage list. The formulary determines whether tens of millions of people with private insurance can easily use an insurance co-pay to buy prescription drugs.

“unconscionable, false and deceptive sales tactics,” including wining and dining, and even flirting with, Oregon doctors.

Oregon entered into a $1.1 million settlement with drugmaker Insys Therapeutics in connection with its marketing of Subsys, an opioid drug.

Price of Addiction: Oregon AG outlines drug-maker’s use of aggressive tactics to win over doctors

http://www.bizjournals.com/portland/blog/health-care-inc/2015/08/price-of-addiction-oregon-ag-outlines-drug-makers.html

When you have attorneys practicing medicine.. this is what you get… they made the determination that cancer pain is dramatically different than non-cancer pain..  All opiates are only FDA approved for cancer pain and they are all used regularly – off label – for non-cancer pains..  The medication involved is Fentanyl.. been around for treating pain.. for a couple of DECADES… Putting medication under the tongue.. sublingual .. its onset is nearly as rapid as a shot… Perhaps none of these attorneys have had migraines and/or they prefer to wait – with a throbbing migraine – for 30-45 minutes for a oral med to start working.  And of course, they state that Fentanyl is HIGHLY ADDICTIVE… not the truth … POTENTIALLY ADDICTING..

Behind the $1.1 million settlement between Oregon Attorney General Ellen Rosenblum and a drug manufacturer lies a tale of “unconscionable, false and deceptive sales tactics,” including wining and dining, and even flirting with, Oregon doctors.

The settlement outlines in great detail how Chandler, Arizona-based Insys Therapeutics went about marketing Subsys, an FDA-approved opioid for cancer pain. The fentanyl-based narcotic is administered with an under-the-tongue spray and rapidly absorbed in the bloodstream.


Price of Addiction: Read more stories in our ongoing series.


The FDA approved Subsys for breakthrough cancer pain, but not other kinds of pain treatment. Insys, however, implicitly misrepresented that Subsys “should be used to treat migraine, neck pain, back pain and other off-label uses for which Subsys is neither safe nor effective,” according to the state Department of Justice’s Notice of Unlawful Trade Practices and Proposed Resolution.

Opioids, including fentanyl and Oxycodone, are highly addictive and often ineffective for chronic pain. Oregon led the nation in nonmedical use of prescription drugs in 2012.

According to the notice, even though Insys knew the drug was being used off-label, the company paid patients’ insurance co-pays, provided free samples and made payments to doctors intended as kickbacks so they’d prescribe Subsys.

Insys, which could not be reached for comment, started promoting Subsys in Oregon in January 2012, selling $511,000 in the state since then. Almost half that amount was prescribed by a single “problem doctor,” according to the notice.

The FDA had stipulated Subsys never be used for migraines, it should only be prescribed by pain specialists and at the lowest possible dose.

Yet within two years of Subsys’ release, 80 percent of its prescriptions were for off-label uses. And the company pressured its sales reps to persuade doctors to prescribe higher doses.

“Insys earns more money when a higher dose is prescribed, as do Insys sales representatives whose compensation is based on commission,” according to the notice.

Insys didn’t focus its efforts on cancer specialists. Instead, it targeted doctors who primarily treat non-cancer pain.

One target was a Tigard doctor identified in court documents only as “Roy,” who cooperated with the investigation. Insys hired the doctor’s son as its Subsys sales rep, even though he had no background in pharmaceutical sales or health care.

Here’s what happened next, according to the notice:

The doctor’s son set up a meeting between his father, Insys regional sales director Beth McKey, and Dr. Stuart Rosenblum, “an anesthesiologist with a long history of speaking on behalf of pharmaceutical companies about drugs, including drugs that were unlawfully promoted off-label to treat certain types of pain,” according to theDepartment of Justice documents. The meeting took place at Riccardo’s Ristorante in Lake Oswego and cost $100 per person.

The son told Insys his father likely wouldn’t prescribe Subsys. On Nov. 1, 2013, he texted his father: “These people from my company are relentless and it’s kind of pissing me off. … I need you to help me to figure out what to say to them to calm them down.”

Insys’ founder contacted his father, McKey proposed “tequila dates” and Insys offered to make Roy a Subsys promotional speaker. The doctor ultimately wrote no prescriptions for Subsys and the son resigned three months into his job.

Insys also targeted “problem doctors,” according to the notice.

For example: one doctor who was not a pain specialist and was ordered by the Oregon Medical Board in late 2013 to cease prescribing controlled substances for chronic pain patients. Insys sales representatives visited the doctor’s office at least 80 times and bought him coffee or snacks on 28 occasions.

Insys paid its top Oregon doctor/consultant $2,400 to speak at a catered lunch. Rosenblum’s office described those talks as “shams” engineered to incentivize doctors to increase Subsys prescriptions. The doctor, though, still wasn’t prescribing enough to satisfy Insys and was told he wouldn’t be used as a speaker again.

 

The DEA has to blame someone else — is the whole agency just plain IRRESPONSIBLE ?

Terry Davis, DEA resident in charge, based in Baton Rouge

DEA agent: High cost of black market prescription pills leads to increase in heroin-related deaths

http://theadvocate.com/news/13102586-123/dea-agent-high-cost-of

In 1914 a Democratic controlled Congress passed The Harrison Narcotic Act and signed by a Democratic President Woodrow Wilson.. which took opiates out of all OTC meds and the courts determined that opiate addiction was a crime.. and threatening any doctors that was discovered to be treating a addict their medical license would be revoked.  This created the black market for opiates and MJ. Then some 55 yrs later another Democratic controlled Congress and a Republican President Nixon created The Controlled Substance Act 1970  that created the BNDD/DEA and declared a war on drugs… to eradicate the black market that they had created decades earlier. Now they are blaming their crack down on the illegal use of legal prescription meds .. for the increase of Heroin use/abuse/deaths.. Is this like a fire fighter that is also a arsonist … that starts fires.. so that he/she can help put them out ?

Heroin-related deaths are on the rise in the Baton Rouge area, and prescription medications are the so-called “gateway drugs” to blame for the problem.

 That’s part of what Terry Davis, the Baton Rouge-based resident agent in charge of the Drug Enforcement Agency for the New Orleans division, shared at a Rotary Club lunch Wednesday.

The high cost of prescription tablets on the black market drive inexperienced dealers to mold heroin with random ingredients into what looks like traditional pills, and unwitting buyers are ingesting them, he said.

“That’s why these heroin overdose deaths are skyrocketing in our region,” said Davis.

Just three ago, in 2012, five people died due to heroin overdoses in East Baton Rouge parish, but those deaths shot up to 34 the following year and were recorded at 28 last year, according to the parish coroner’s office. This year, there already have been 22 such deaths in the parish, said Coroner Dr. William “Beau” Clark.

The increase mirrors a national trend in heroin-related deaths, which nearly quadrupled from 2002 to 2013, according to the Centers for Disease Control and Prevention.

Two Baton Rouge doctors — Walter Ellis and James Hines — were arrested due to DEA investigations into illegal prescription drug distribution over the past year and a half.

Terry said purchasing illegal prescription drugs can take the hard edge off the illicit transactions.

“I know when I did undercover, I actually preferred buying pills to crack because the transactions were safer, they were quicker and there was less negotiation,” he said.

And one factor to eye might be the recreational use of pills by college students, he said.

“Adderall, of course, is like sweet tarts for a college student, unfortunately” he said, referring to a medication intended to treat attention problems misused by some students for intense studying.

While not all college-aged drug users graduate to serious prescription pill abuse, many do, especially in the context of apathetic or uninformed parents, he said.

“Once they jump that hurdle and become more desperate, we tend to see it more.”

Teach kids to dance and they won’t become addicts ? WTF ?

DEA Youth Dance program keeps kids off drugs, teaches lifelong skills

http://q13fox.com/2015/08/05/dea-youth-dance-program-keeps-kids-off-drugs-teaches-lifelong-skills/

AUBURN, Wash. — “Dance like no one is watching!”

You’ve heard that saying before, but what about “dance like the DEA is watching?”

A new program is helping local kids stay away from drugs and explore their talents.

A look inside Shaun King’s moves at Auburn Dance Academy is like peering into his soul.

“Really, dance is what I love to do,” he said.

Just a few years ago, he’d never set foot in a dance studio. Then, the DEA came to his school to talk about the DEA Youth Dance Program.

“Enforcement for DEA is our priority. Putting bad guys in jail. However we recognize there’s another component to that and that is educating people to the dangers of drugs and giving them a positive alternative and the Youth Dance Program is that alternative for students.” said Acting Special Agent in Charge Doug James.

For Shaun, the hip-hop moves helped him grow from a shy kid to a bold dancer. He used to struggle with bullies.

“He has just really opened up a lot. Instead of hiding under table, he’s dancing and coming out of himself,” said his mom Celeste Locke.

“It’s really neat to find your child find that thing they love more than anything else.”

His coach has seen a difference in every step.

“When I first meet Shaun, he was very, very shy. He didn’t talk much. Now, he’s the most outgoing!” said Chris Carrington.

Shaun and his team just returned from a national competition in Las Vegas where they took 1st place.  Shaun doesn’t know yet what he wants to be when he grows up but you can be that the beat will follow him.

“The cool thing about dance is the life lesson they will carry with them. They’re dedicated and focused. They will be successful in everything they do,” said Jennifer Carrington who owns Auburn Dance Academy with her husband.

The Seattle area DEA’s Youth Dance Program is a non-profit currently partnered with two dance companies: The Massive Monkees and Auburn Dance Academy.

Six after school programs will be running for the 2016-2016 school year in the greater Seattle area.

Local indy Pharmacy ONE-THIRD the cost of WALGREENS on Rxs ?

County upset with jail bill for prescriptions

http://www.mitchellrepublic.com/news/local/3811016-county-upset-jail-bill-prescriptions

The Davison County Commission took aim at the cost of providing medical care at the Davison County Jail again Tuesday, this time targeting drug retailer Walgreens.

 

It left some commissioners with strong words about Walgreens during the regular commission meeting Tuesday at the Davison County North Offices in Mitchell.

“I think we’re just done with them personally,” Weitala said. “You look at that bill, and it’s just horrific.”

The county met with representatives for the Mitchell Walgreens in April, but Weitala said much of the price decisions on drugs were made at the corporate level. Records earlier this year showed the county paid nearly $36,000 to Walgreens in 2014, which was the most the county jail paid to any one entity, including hospitals and ambulance providers.

Weitala said some prescriptions run as much as $900 per order for the county.

“We’re just looking at the overall expenses,” she said. “Between medical and dental, we’re getting the ‘go to the jail and get your body fixed’ thing.”

Davison County Sheriff Steve Brink, who oversees the jail as part of his duties, apologized for the costs, which he described as out of hand. He said he didn’t realize what the county is spending on medicine.

“The more I think about it, the more upsetting it is,” Brink said. “It upsets me that something like that could even happen. It’s almost criminal.”

Davison County Jail Administrator Don Radel said the county doesn’t have a contract with Walgreens, but has a verbal agreement for the company to be the jail’s primary provider for medicine.

Weitala said she’s not sure how the county ended up in this situation, but wants to fix the problem.

“It’s over now with those past bills,” she said. “We don’t make any money off the jail to begin with, so for this to go unchecked as long as it has is just unacceptable.”

Lewis Drug, for example, would deliver the medicine to the jail and fill orders on Saturdays, which is currently done by Walgreens.

“It’s not a question of the service,” said Commission Chairman John Claggett. “It’s the price point.”

County approves raises, vacation plan

After tweaking a proposal presented last week, the Davison County Commissioners have approved raises for numerous county employees.

The proposal’s increase was lowered from 3.7 percent to 2.8 percent, for a total increase of $128,404 to the payroll. The commission voted 4-1 to approve the raises, with only Commissioner Brenda Bode voting in opposition.

Commissioners Weitala and Randy Reider consulted Monday with study leaders Jeff Bathke and Susan Kiepke to revise the overall amount of raises to be given. The tweaks included lowering the raises proposed for the auditor, treasurer, register of deeds and state’s attorney, although all four positions will still receive increases in pay compared to their current wages. Weitala and Reider also decided Bathke’s combined position as emergency management and planning and zoning director is worthy of a raise.

Commissioner Denny Kiner said the figures were substantiated by data and worth putting into place as soon as possible. One of the key aspects of the salary schedule is to put minimum and maximum starting wage figures in place, so there will be less haggling over what a new employee makes.

“We need to hold firm on this,” he said. “It sets the standard that we’re going to go by.”

The raises are effective for the first pay period of September, which starts Sept. 4. The raises will be included in the 2015 budget, and cost-of-living raises are still expected for 2016. Along with the increases in pay for some employees, the county is changing its protocol for how vacation time is administered for new employees with less than one year of service time. Those employees will now receive 3.25 hours of vacation time per pay period, instead of earning vacation time at the previous rate of 1.6 hours per pay period. The change allows employees to earn two weeks’ vacation time faster, instead of being capped at one week. New employees will still not be allowed to take vacation during their first six months, unless they have a special exception.

Bode said she received numerous calls from concerned citizens who are upset with the raises, especially for elected officials.

“I got very negative comments,” she said. “I do understand when taxpayers say that they know that the wage is when they ran for the position. I don’t really have an answer for that.”

Claggett said he feels it’s important to keep up, and that it comes down to the amount of time people put into the position.

“For the public, it’s a perception piece more than the reality piece,” he said.

Bode said she voted no for the raises because she felt she had to represent the comments taxpayers made to her.

“The focus shouldn’t just be on the money,” Bode said following the meeting. “There’s so much more that needs to be done as far as making our employees better, through training and development. That’s where our focus needs to be.”

Commissioners also discussed the way they could improve year-end reviews between employees and supervisors, and also to meet with department heads as a group during the Aug. 11 meeting to clearly explain the policy changes.

 

Pain Patients Say They Can’t Get Medicine After Crackdown On Illegal Rx Drug Trade

Pain Patients Say They Can’t Get Medicine After Crackdown On Illegal Rx Drug Trade

http://www.kitsapsun.com/news/state/pain-patients-say-they-cant-get-medicine-after-crackdown-on-illegal-rx-drug-trade_39596939

The accident happened 10 years ago when Chris Young was 35. He owned a salvage yard in Maui, Hawaii, and his employee had hoisted a junker on a machine called an excavator when the hydraulics gave out. The car fell on him from above his head, smashing his spine.

“He was crushed accordion-style,” says his wife Lesley.

The accident left Young with a condition known as “partial paraplegia.” He can’t walk and he needs a wheelchair, but he does have some sensation in his legs. Unfortunately for Young, that sensation is often excruciating pain.

“It feels like electric shocks, like lightning bolts going down my legs. And when it gets down to the bottom, it feels like someone is driving a big metal spike up my legs,” says Young.

To control the pain, Young, who has since moved to Florida, needs high doses of narcotic painkillers, but he can’t always fill his doctor’s prescription. He is not alone. In what may be an unintended side effect of a crackdown on prescription drug abuse, Young and other legitimate chronic pain patients are having increasing trouble getting the medicine that allows them to function on a daily basis.

Young’s pharmacy runs out every month.

“They just do not have the medications because they have run out of their allocation within the first week,” he says. “It’s just that bad, where I know I am going to end up in the E.R. because of not having my medications. We don’t know what to do. We’ve tried everything.”

Young’s pharmacist is Bill Napier, who owns the small, independent Panama Pharmacy in Jacksonville. Napier says he can’t serve customers who legitimately need painkillers because the wholesalers who supply his store will no longer distribute the amount of medications he needs.

“I turn away sometimes 20 people a day,” says Napier.

Last year Napier says federal Drug Enforcement Administration agents visited him to discuss the narcotics he dispensed.

“They showed me a number, and they said that if I wasn’t closer to the state average, they would come back. So I got pretty close to the state average,” Napier says. He says he made the adjustment “based on no science, but knowing where the number needed to be. We had to dismiss some patients in order to get to that number.”

According to Napier, DEA agents took all of his opioid prescriptions and held on to them for seven months. Napier hired a lawyer and paid for criminal background checks on his patients taking narcotics to help him decide which ones to drop.

“We’re being asked to act as quasi-law enforcement people to ration medications,” says Napier. “I have not had training in the rationing of medications.”

Until a few years ago, Florida was considered the epicenter for the trafficking of illegal prescription narcotics. The DEA and local law enforcement shut down more than 250 so-called “pill mills” – clinics where doctors could sell narcotics directly to people for cash. Now Florida doctors can no longer dispense narcotics directly to patients. Wholesalers, who paid to settle claims for failing to report suspicious orders of drugs, now limit the amount they sell to pharmacies, Napier says.

Jack Riley, who is acting deputy administrator of the DEA, credits a decline in opioid overdose deaths in Florida with an upsurge in law enforcement activity. The problem of addiction and the drug trade is dire, he says.

“A hundred and twenty people a day die of drug abuse in this country,” Riley said. “If that doesn’t get your attention, I don’t think anything can.”

Riley also says law enforcement efforts cannot be blamed for any claim of rationing of painkillers.

“I’m not a doctor. We do not practice medicine. We’re not pharmacists. We obviously don’t get involved in that,” said Riley. “What we do do is make sure the people that have the licenses are as educated as possible as to what we’re seeing, and that they can make informed decisions as they do dispense.”

Doctors, too, say DEA enforcement actions have made it harder for them to prescribe narcotics. Last year, hydrocodone products, such as Vicodin, were changed to Schedule II status, meaning they have a high potential for abuse and cannot be prescribed in large quantities.

“What we’ve seen is dramatic reductions in our ability to provide appropriate care for our patients in pain,” says Dr. R. Sean Morrison, director of the palliative care program at Mount Sinai Hospital in New York.

Morrison’s patient Ora Chaikin has been taking high levels of narcotics for years to control her pain. She has had multiple surgeries because her bones and ligaments disintegrate, a problem caused by rheumatoid arthritis and other autoimmune diseases. But Chaikin, who lives in Riverdale, N.Y., says her mail order pharmacy, CVS/caremark, has been denying her medications.

“Every month there’s a reason they won’t give me my medication,” says Chaikin. “Sometimes it’s ‘Well, why are you taking this dose?’ ‘My doctor prescribed it.’ ‘Well, why did your doctor prescribe so much?’ ‘Ask my doctor,'” she recounts. “That’s the dose that works for me and you’re made to feel like a drug addict.”

The DEA investigated both CVS and Walgreens, and both pharmacy chains settled civil suits in 2013 for record-keeping violations of the Controlled Substances Act. Walgreens paid an $80 million civil penalty, and CVS paid an $11 million penalty.

Riley, of the DEA, says it would be wrong to draw a line between these actions and problems like those Chaikin is experiencing. “If there is a chilling effect, it’s clearly not at our direction,” Riley said. “We’re simply enforcing the law, taking bad people off the street and really trying to interrupt the supply of illegal prescriptions.”

In a statement, CVS/caremark said that the dosage of pain medication prescribed to Chaikin “exceeded the recommended manufacturer dosing.” It also said that she “continued to receive her controlled substance prescriptions from CVS/caremark without interruption.”

CVS/caremark said it has a legal obligation to make sure controlled substance prescriptions are for legitimate ailments and “that patients are receiving safe medication therapy, including appropriate dosing.”

Ora Chaikin’s wife, Roseanne Leipzig, who is a geriatrician and palliative care physician, says when it comes to narcotics, there is nothing in medical literature that says a dose is too high.

“There is no maximum dose for narcotics,” she says. “It’s the dose you need to take care of the pain.”

The Florida Board of Pharmacy, which is responsible for licensing pharmacists and educating them on safe practice, has heard enough complaints from pain patients that it is addressing the issue in public meetings. In June, Lesley Young testified before the board on behalf of her husband. She said she has driven more than 100 miles trying to find a pharmacy that would fill her husband’s prescriptions for painkillers.

“I’ve had to do the pharmacy crawl like many of us here,” Lesley told the board. “I’ve been the one who had to go in and beg, crying, with stacks of his medical records, with stacks of imaging, only to get turned away, often rudely, saying ‘We don’t deal with those kinds of patients.'”

The next Florida Board of Pharmacy hearing is set for Monday. A representative of the DEA has been invited to attend.

This story was produced in a collaboration between NPR’s Here & Now and Kaiser Health News.

Kaiser Health News (KHN) is a national health policy news service. It is an editorially independent program of the Henry J. Kaiser Family Foundation.

Study: Teen Marijuana Use Has No Link To Mental Health Problems

Study: Teen Marijuana Use Has No Link To Mental Health Problems

Chronic marijuana use as an adolescent has no link to mental or physical health problems later in life, according to a new study conducted over the past 20 years.

Published by the American Physiological Association, researchers from the University of Pittsburgh Medical Center and Rutgers University divided participants into four groups from their teenage years onward.

One group almost never smoked marijuana, one used it mostly in their teenage years, another started using in adulthood and the final group of subjects started using marijuana early and continued into their adult years.

There had been some evidence to suggest that regular marijuana use among teenagers was linked to mental problems such as depression and schizophrenia. Indeed, lead researcher Jordan Bechtold was expecting to find similar results and said what they discovered was “a little surprising.”
The study found that “chronic marijuana users were not more likely than late increasing users, adolescence-limited users, or low/nonusers to experience several physical or mental health problems in their mid-30s.”

In fact, there were no significant differences between marijuana trajectory groups in terms of adult health outcomes, even when models were run without controlling for potential confounds. The researchers found no link between teen marijuana use and lifetime depression, anxiety, allergies, headaches or high blood pressure.

The study also breaks new ground in that it was able to track 408 subjects as they grew up, rather than looking back on marijuana use retrospectively to find a link with current health problems. All the subjects were male and the study controlled for factors such as cigarette smoking and socioeconomic background.

Although the researchers caution that a single study shouldn’t be looked at in isolation, they argue it should contribute to debate surrounding marijuana legalization. Washington, Colorado, Alaska and Oregon have already legalized recreational marijuana use and campaigners are hoping to push the reforms nationwide.

“Everyone wants to prevent teen marijuana use, but we don’t need to exaggerate its harms and arrest responsible adults in order to do it,” Mason Tvert, communications director at the Marijuana Policy Project, told The Daily Caller News Foundation.

“Hopefully, this study will lead to a reevaluation of the tactics that are being used to discourage teens from trying marijuana,” he added.

Follow Guy on Twitter
Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact licensing@dailycallernewsfoundation.org.

 

an average of 7 errors happens each month at every pharmacy across the US

skullandbones

an average of 7 errors happens each month at every pharmacy across the US

There are 60+ K pharmacies.. which means that there is abt 500,000 med errors every year in the USA

Giving a correctly dispensed prescription to the wrong pharmacy patient is a common error in community pharmacies. If this has never happened to you, maybe you’re surprised by this fact. But you are more likely to be among the millions of people who have gone home from the pharmacy only to find they have someone else’s medicine inside the pharmacy bag. 

A study conducted by my organization (ISMP) found that this error happens about once for every 1,000 prescriptions. With close to 4 billion prescriptions dispensed from pharmacies each year, an average of 7 errors happens each month at every pharmacy across the US.

Most people trust that the pharmacist will fill their prescriptions accurately. In fact, Americans have rated pharmacists as one of the most trusted professions for years. Yes, pharmacists deserve the trust we’ve placed in them. But they are human and could make a mistake, as could the person who rings up the sale. 

Giving a correctly dispensed prescription to the wrong patient can happen for several reasons. First, a mistake can be made when placing the prescription in a bag for pick-up. These errors often stem from working on more than one patient’s prescription at a time, and then placing the medicine in the wrong bag. Most people pick up their medicine and leave the pharmacy without ever opening the bag. Furthermore, many pharmacies do not require their workers to open the bag prior to ringing up the sale. So, they do not look at each prescription in the bag when giving it to the patient to be sure it is for the correct person. People may notice the error once they get home, especially if the medicine looks different than expected. But a government study shows that only about half of patients confirm their name on the prescription label, and only about three-quarters confirm the medicine’s name prior to taking the medicine. As a result, many people have taken the wrong patient’s medicine.

Another way a correctly prepared prescription can be given to the wrong customer is when pharmacy workers select the wrong bag of medicines for customers. The process of identifying the customer can be incorrect if both a full name and date of birth are not asked for and provided at the time of sale. Some pharmacy workers believe they know their customers by sight and have not developed the safe habit of always asking customers to state their full name and date of birth. Or, caregivers, friends, and even family members who pick up prescriptions for the patient may not know the patient’s date of birth. Thus, the wrong customer’s bag may be chosen if there are medicines in the pick-up area for customers with the same or a similar last name. Using an address to identify customers is not ideal, as people with the same last name often live together.    

If you do not notice the error and take another patient’s medicine, it could be a medicine that should never be taken given your current health condition, allergies, or other medicines you are taking. For example, a pregnant woman who intended to fill a prescription for an antibiotic to treat an infection was accidentally given another woman’s prescription for methotrexate instead. Both women had the same last name and very similar first names. The pregnant woman took one tablet of methotrexate before noticing the error. Methotrexate is a medicine used to treat certain cancers or other conditions such as rheumatoid arthritis and psoriasis. The medicine prevents cell growth and should never be taken by a pregnant woman. It can cause birth defects in the brain, bone, and heart, or cause a miscarriage. The pregnant woman was seen in the emergency department, but it was too early to determine if the unborn child had been harmed.

Another problem with receiving and taking the wrong patient’s medicine is that you may not be taking the correct medicine prescribed for you. This can lead to untreated health conditions that can worsen over time or cause other adverse effects on your health. For example, a patient who had been prescribed an antibiotic for a serious bacterial infection accidentally received another patient’s medicine, sertraline (Zoloft), to treat depression. After 10 days, the patient became very ill as the infection raged on untreated. Another patient had been prescribed a pain reliever but instead received another patient’s prescription for allopurinol, a gout medicine. After days of pain without relief, she noticed the error and called the pharmacy to correct the mistake.   

Customers who are accidentally given the wrong patient’s medicines have occasionally misused these medicines for recreational purposes or to harm themselves. In one case, a customer went to the pharmacy to pick up prescriptions for an allergy medicine and oxycodone, a narcotic pain reliever. The pharmacy found that the prescriptions had accidentally been given to another customer. When this customer was called, he denied receiving the wrong prescription, presumably because of the oxycodone—a common drug of abuse. In another case, a woman who had picked up a prescription for Premarin (estrogen) found another patient’s medicine also in the bag when she arrived home. The medicine was amitriptyline (Elavil), a medicine to treat depression. Later, a pharmacist received a call from a local hospital to tell her the woman was in the emergency department after taking 30 amitriptyline tablets dispensed by the pharmacy for another patient, in what appeared to be a suicide attempt.

Another unfortunate aspect of this type of error is that confidential information is shared with the person who receives another person’s medicine. The full name and address of the patient, along with the drug name, are on the pharmacy label. For sensitive medicines, such as psychiatric medicines or medicines that treat human immunodeficiency virus (HIV), patients may be deeply troubled that another person is aware of this information.       

So yes, these errors do happen and they are not uncommon, as nearly every community pharmacist would admit. In my next blog I’ll detail easy steps you can take to prevent these problems from affecting you or a member of your family. 
Read more at http://www.philly.com/philly/blogs/healthcare/Getting-the-wrong-persons-medicine-at-the-pharmacy.html#gHlpwI9yGGAWbLSt.99